The Effect of Atorvastatin (and Subsequent Metformin) on Adipose Tissue Acylation-Stimulatory-Protein Concentration and Inflammatory Biomarkers in Overweight/Obese Women With Polycystic Ovary Syndrome

<h3>Background</h3><p dir="ltr">Atorvastatin has been shown to improve cardiovascular risk (CVR) indices in women with polycystic ovary syndrome (PCOS). Low-grade chronic inflammation of adipose tissue may link PCOS and adverse CVR. In pro-inflammatory states such as PCOS...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Thozhukat Sathyapalan (704787) (author)
مؤلفون آخرون:	James P. Hobkirk (18140275) (author), Zeeshan Javed (9975180) (author), Sean Carroll (1723798) (author), Anne-Marie Coady (18140278) (author), Philip Pemberton (18140281) (author), Alexander Smith (326930) (author), Katherine Cianflone (155973) (author), Stephen L. Atkin (6684368) (author)
منشور في:	2019
الموضوعات:	Biomedical and clinical sciences Clinical sciences atorvastatin acylation-stimulating-protein interleukin-6 monocyte-chemoattractant-protein-1 adipose tissue PCOS
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

The Effect of Atorvastatin (and Subsequent Metformin) on Adipose Tissue Acylation-Stimulatory-Protein Concentration and Inflammatory Biomarkers in Overweight/Obese Women With Polycystic Ovary Syndrome

مواد مشابهة